Visceral leishmaniasis: rapid response to AmBisome treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7574862.
- Also identified by PMC identifier 1511183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There appears to be an increase in imported cases of visceral leishmaniasis in Northern Europe; many are children infected on holiday in the Mediterranean. Making the diagnosis in young children can be difficult especially when an adequate travel history is not obtained at presentation. Two infants with visceral leishmaniasis are presented who were initially felt to have alternative diagnoses and who subsequently responded dramatically to a short course of liposomal amphotericin B (AmBisome).
Medical subject headings
- Amphotericin B
- Antiprotozoal Agents
- Leishmaniasis, Visceral